Implications of serotonin transporter distribution in the healthy and diseased human brain, investigated by positron emission tomography

نویسندگان

  • Georg S. Kranz
  • Rupert Lanzenberger
چکیده

......................................................................................................................................................... v Kurzfassung ................................................................................................................................................... vi Publications arising from this thesis ............................................................................................................ viii Acknowledgments and project funding ........................................................................................................ ix I. BACKGROUND ............................................................................................................................. 1 1.1. General introduction ............................................................................................................................. 1 1.2. The serotonin transporter (SERT) and its role in psychiatry and psychopharmacological treatment .. 2 1.2.1. SERT structure and function .................................................................................................. 2 1.2.2. SERT regulation ...................................................................................................................... 5 1.2.3. SERT blockage in relation to antidepressant treatment ....................................................... 7 1.3. Quantification of the brain SERT with PET and [C]DASB..................................................................... 9 1.3.1. PET and SPECT to study the SERT .......................................................................................... 9 1.3.2. PET and SPECT radiopharmaceuticals for the SERT............................................................. 11 1.3.3. Quantitative data analysis ................................................................................................... 12 1.4. Imaging the SERT in the healthy and diseased human brain .............................................................. 16 1.4.1. SERT distribution in the human brain.................................................................................. 16 1.4.2. Imaging the SERT in psychiatric disorders ........................................................................... 18 1.4.3. SERT occupancy measured with PET and its relation to treatment outcome..................... 20 1.5. Open questions .................................................................................................................................... 21 II. AIMS OF THE THESIS .................................................................................................................. 23 III. RESULTS .................................................................................................................................... 24 3.1. First publication: Cerebral Serotonin Transporter Asymmetry in Females, Males and Male-to-Female Transsexuals measured by PET in vivo ..................................................................... 24 3.1.1. Abstract ............................................................................................................................... 25 3.1.2. Introduction ......................................................................................................................... 26 3.1.3. Material and methods ......................................................................................................... 28 3.1.4. Results ................................................................................................................................. 30 3.1.5. Discussion ............................................................................................................................ 34 3.1.6. Conclusions .......................................................................................................................... 38 3.1.7. References ........................................................................................................................... 39

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Seasonal variation in human brain serotonin transporter binding.

CONTEXT It is a common experience in temperate zones that individuals feel happier and more energetic on bright and sunny days and many experience a decline in mood and energy during the dark winter season. Brain serotonin is involved in the regulation of physiologic functions, such as mating, feeding, energy balance, and sleep. Although these behaviors and serotonin-related conditions show a c...

متن کامل

Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2

Background The norepinephrine transporter in the brain has been targeted in the treatment of psychiatric disorders. Duloxetine is a serotonin and norepinephrine reuptake inhibitor that has been widely used for the treatment of depression. However, the relationship between dose and plasma concentration of duloxetine and norepinephrine transporter occupancy in the human brain has not been determi...

متن کامل

Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder.

BACKGROUND Several lines of evidence implicate abnormal serotonergic function in suicidal behavior and completed suicide, including low serotonin transporter binding in postmortem studies of completed suicide. We have also reported low in vivo serotonin transporter binding in major depressive disorder (MDD) during a major depressive episode using positron emission tomography (PET) with [(11)C]M...

متن کامل

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

BACKGROUND (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") is a popular recreational drug that selectively damages brain serotonin (5-HT) neurons in animals at doses that closely approach those used by humans. We investigated the status of brain 5-HT neurons in MDMA users. METHODS We enrolled 14 previous users of MDMA who were currently abstaining from use and 15 controls who had nev...

متن کامل

Association of Protein Distribution and Gene Expression Revealed by PET and Post-Mortem Quantification in the Serotonergic System of the Human Brain.

Regional differences in posttranscriptional mechanisms may influence in vivo protein densities. The association of positron emission tomography (PET) imaging data from 112 healthy controls and gene expression values from the Allen Human Brain Atlas, based on post-mortem brains, was investigated for key serotonergic proteins. PET binding values and gene expression intensities were correlated for...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013